BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15188131)

  • 1. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.
    Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS
    Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
    Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
    Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of beta-catenin is associated with poor survival in ovarian carcinomas.
    Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Lopes CS
    Int J Gynecol Pathol; 2004 Oct; 23(4):337-46. PubMed ID: 15381903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
    Fujioka T; Takebayashi Y; Kihana T; Kusanagi Y; Hamada K; Ochi H; Uchida T; Fukumoto M; Ito M
    Oncol Rep; 2001; 8(2):249-55. PubMed ID: 11182035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
    Stawerski P; Wagrowska-Danilewicz M; Stasikowska O; Gottwald L; Danilewicz M
    Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas.
    Imai T; Horiuchi A; Shiozawa T; Osada R; Kikuchi N; Ohira S; Oka K; Konishi I
    Hum Pathol; 2004 Dec; 35(12):1469-76. PubMed ID: 15619205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
    Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
    Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract.
    Li CC; Xu B; Hirokawa M; Qian Z; Yoshimoto K; Horiguchi H; Tashiro T; Sano T
    Virchows Arch; 2002 Feb; 440(2):145-54. PubMed ID: 11964044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis.
    Salon C; Moro D; Lantuejoul S; Brichon Py Py; Drabkin H; Brambilla C; Brambilla E
    Hum Pathol; 2004 Sep; 35(9):1148-55. PubMed ID: 15343518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
    Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
    Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas.
    Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Lopes CS
    Ann Oncol; 2004 Oct; 15(10):1535-42. PubMed ID: 15367415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of e-cadherin and catenins in early gastric cancer.
    Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
    J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
    Joo YE; Rew JS; Park CS; Kim SJ
    Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma.
    Ikeguchi M; Makino M; Kaibara N
    J Surg Oncol; 2001 Jul; 77(3):201-7. PubMed ID: 11455558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
    Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
    Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.
    Kase S; Sugio K; Yamazaki K; Okamoto T; Yano T; Sugimachi K
    Clin Cancer Res; 2000 Dec; 6(12):4789-96. PubMed ID: 11156236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.